Have recent evolutions in European governance brought harmonisation in the field of illicit drugs any closer?

Abstract

With the long awaited ratification of the Lisbon Treaty on 1 December 2009, it appears that plans within Europe to achieve an ‘ever closer union’ are back on track, yet, in the field of illicit drug policy, harmonisation remains as elusive a goal as ever. Sweden and the Netherlands have long provided examples of the different paradigms of drug policy operating within Europe and this article seeks to examine whether, as European Union harmonisation moves forward, recent developments bring the two any closer to convergence on this contentious issue. In addition to changes in Swedish and Dutch drug policy, the progress of the drug policy of other European countries has been evaluated. The article concludes that the Swedes and the Dutch remain ultimately wedded to their national policies and that movement both towards increased repression of drug use and increased liberalisation of drug use can be observed among other European countries. Harmonisation of European drug policy therefore remains in a state of stalemate.